35 results
8-K
EX-99.1
HTCR
HeartCore Enterprises Inc
8 Apr 24
HeartCore Reports Full Year 2023 Results and Provides Strategic Priorities for 2024
5:21pm
and research and development expenses, offset by a decrease in selling expenses.
Net loss was about $4.9 million or $(0.21) per diluted share compared
8-K
EX-99.1
HTCR
HeartCore Enterprises Inc
13 Nov 23
HeartCore Reports Third Quarter 2023 Financial Results
8:30am
was primarily due to general and administrative expenses and research and development expenses, slightly offset by decreases in selling expenses.
Net loss … period last year. The increase was primarily due to increases in general and administrative expenses, offset by a decrease in selling expense
424B5
HTCR
HeartCore Enterprises Inc
23 Oct 23
Prospectus supplement for primary offering
4:43pm
to offset the decline in sales in the CX and DX divisions.
The duration and extent of the impact from the pandemic depends on future developments that cannot
8-K
EX-99.1
69w9irh0idzc3
14 Aug 23
HeartCore Reports Second Quarter 2023 Financial Results
8:00am
424B5
chrn7vqvzo4wykfdpqs
31 May 23
Prospectus supplement for primary offering
2:30pm
S-3/A
3vv3g62pmo3zit66z0a
7 Apr 23
Shelf registration (amended)
4:01pm
8-K
EX-99.1
twvbibtu gq1rhp
30 Mar 23
HeartCore Reports Fourth Quarter and Full Year 2022 Financial Results
4:06pm
8-K
EX-99.1
cl6q9njqbo0earye0
15 Aug 22
HeartCore Reports Second Quarter 2022 Financial Results
8:30am
DEF 14A
y6bqh zp2
20 Jul 22
Definitive proxy
9:05am
10-Q
qd3ki5snbp9tlqf3aco
16 May 22
Quarterly report
4:27pm
8-K
EX-99.1
ekinruhdrv81pn
16 May 22
HeartCore Reports First Quarter 2022 Results
4:21pm
10-K
tblmanus
31 Mar 22
Annual report
4:06pm